UT-MD Anderson Cancer Center: New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer
May 29, 2025
May 29, 2025
HOUSTON, Texas, May 29 (TNSjou) -- The University of Texas MD Anderson Cancer Center issued the following news release:
* * *
New biomarker may guide best use of KRAS inhibitors in lung cancer
* Lung cancer patients with high TTF-1 expression had improved survival outcomes following treatment with the KRAS inhibitor, sotorasib
* This biomarker may help physicians determine those most likely to benefit from sotorasib and those who may need alter . . .
* * *
New biomarker may guide best use of KRAS inhibitors in lung cancer
* Lung cancer patients with high TTF-1 expression had improved survival outcomes following treatment with the KRAS inhibitor, sotorasib
* This biomarker may help physicians determine those most likely to benefit from sotorasib and those who may need alter . . .